Cannabix Technologies Unveils Innovative Breathalyzer Systems
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) is making noteworthy progress in drug testing technology. They’ve recently revealed plans to showcase their new marijuana breathalyzer system at an upcoming conference. This exciting event will be hosted at the Society of Forensic Toxicologists (SOFT) conference, where Cannabix Senior Advisor, Dr. Bruce Goldberger, is set to present key advancements in drug and impairment testing to attendees.
Key Features of the Cannabix Breathalyzer
In partnership with Omega Laboratories Inc., Cannabix has introduced a range of enhancements to its marijuana breathalyzer technology. These improvements are specifically crafted to meet the demands of today's market and adhere to evolving regulatory standards. The upgraded Breath Collection Unit now features periodic quality assurance checks and the ability to collect ambient air samples, enhancing breath-based testing protocols.
Advancements and Collaborations
Through its strategic alliance with Omega Laboratories, Cannabix and Omega are making significant headway. They are establishing detection and quantification limits for breath samples, particularly focused on measuring delta-9 THC levels, which is the primary psychoactive compound in cannabis. Omega has made strides in detecting delta-9 THC even at very low levels, enabling precise measurements that are essential for regulation and enforcement.
Dr. Bruce Goldberger's Contributions
Dr. Bruce Goldberger is a leading authority in forensic toxicology. With over thirty years running the forensic toxicology laboratory at the University of Florida, his input for the conference presentation is greatly anticipated. He’s not only a well-respected educator but also the principal investigator for numerous important drug-related research projects, which will bolster the credibility of Cannabix's presentation.
About Omega Laboratories Inc. and Their Influence
Headquartered in Mogadore, Ohio, Omega Laboratories has positioned itself as a premier player in forensic drug testing. Their collaboration with Cannabix Technologies aims to enhance breathalyzer technology by leveraging their expertise in drug detection. They serve a broad clientele, offering advanced testing solutions to various organizations around the globe, including corporate clients and law enforcement agencies.
The Future of Cannabis Testing Technologies
As Cannabix develops its breathalyzer for detecting delta-9 THC, they are also exploring related technologies for alcohol screening. This forward-thinking approach not only supports workplaces and law enforcement but also engages with ongoing discussions about safety in the workplace concerning cannabis use. With Cannabix's innovative spirit and Omega's extensive background in drug testing, the outlook for drug assessment technologies appears bright.
Frequently Asked Questions
What is Cannabix Technologies known for?
Cannabix Technologies specializes in developing breathalyzer technologies for marijuana and alcohol, catering to law enforcement, workplaces, and laboratories.
Who is Dr. Bruce Goldberger?
Dr. Bruce Goldberger is a well-known forensic toxicologist and educator with a wealth of experience managing drug testing laboratories.
What are the new features in the Cannabix breathalyzer?
The new breathalyzer comes equipped with periodic quality assurance checks, ambient air sampling capabilities, and updates for dual sample collection, which improve its reliability and accuracy.
How is Omega Laboratories involved with Cannabix?
Omega Laboratories partners with Cannabix to enhance and advance the marijuana breathalyzer, utilizing their deep expertise in drug detection technologies.
What is the importance of detecting delta-9 THC?
Detecting delta-9 THC is vital for determining recent cannabis use, which plays a crucial role in regulatory compliance and maintaining safety across various environments.
